CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hester Pharmaceuticals Limited Company Snapshot
Hester Pharmaceuticals Limited operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hester Pharmaceuticals Limited with three other pharmaceutical manufacturers in Asia: Biocon Limited (2019 sales of 55.14 billion Indian Rupees [US$770.91 million] of which 33% was Research Services), Panacea Biotec Ltd (4.57 billion Indian Rupees [US$63.85 million] ), and Atect Corp which is based in Japan (2.96 billion Japanese Yen [US$27.81 million] ).

Sales Analysis. During the year ended March of 2019, sales at Hester Pharmaceuticals Limited were 1.78 billion Indian Rupees (US$24.89 million). This is an increase of 31.0% versus 2018, when the company's sales were 1.36 billion Indian Rupees. This was the fifth consecutive year of sales increases at Hester Pharmaceuticals Limited (and since 2014, sales have increased a total of 158%). Sales of Others saw an increase that was more than double the company's growth rate: sales were up 2,125.7% in 2019, from 2.28 million Indian Rupees to 50.82 million Indian Rupees. Hester Pharmaceuticals Limited also saw significant increases in sales in Large Animal Health Production (up 127.0% to 426.45 million Indian Rupees) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hester Pharmaceuticals Limited
  Stock Performance Chart for Hester Pharmaceuticals Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 1,684.70
(Figures in Indian Rupees)
1 Week 1.1%   13 Weeks 0.0%  
4 Weeks 11.1%   52 Weeks 24.8%  
 
Hester Pharmaceuticals Limited Key Data:
  Ticker: HESTERBIO Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 1,780,667,731
(Year Ending Jan 2020).
Employees: 448
  Currency: Indian Rupees Market Cap: 14,331,515,466
  Fiscal Yr Ends: March Shares Outstanding: 8,506,865
  Share Type: Ordinary Closely Held Shares: 4,987,576
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.